Merck’s Vioxx Conduct Receives Passing Grade In Review By Outside Firm
Executive Summary
An independent report contracted by Merck has concluded that the company's senior executives did not mishandle the development, testing and marketing of Vioxx (rofecoxib), despite the fact that the product is widely viewed as one of the more significant debacles in pharmaceutical history